| Aptamer ID | Aptamer descriptor | Target chemistry | Target name | Affinity | Binding Conditions/Buffer | PubMed ID |
|---|---|---|---|---|---|---|
| Apta_795 | ZL-7c | Cell | HCC cell (HepG2/MDR) | 86.26 nM | DPBS with glucose (4.5 mg/mL), MgCl2 (5 mM), BSA (1 mg/mL), and yeast tRNA (0.1 mg/mL)) at 37 °C in an orbital shaker for 50 min | 34779207 |
| Aptamer Sequence: | CGCAGCAAGGAGATTCGAGGGGGAAGGTTTGTTATAGGGGTTAATGGA |
| The optimal secondary structure in dot-bracket notation: | ...((((((....(((......)))..))))))............... |
| The centroid secondary structure in dot-bracket notation: | ...((((((....(((......)))..))))))............... |
| Type | Detail | Type | Detail |
|---|---|---|---|
| Aptamer ID | Apta_795 | Description | ZL-7c |
| Aptamer chemistry | DNA | Length | 48 nt |
| GC content | 50.0% | Molecular weight | 15,096.69 Da |
| Molarity of 1 μg/μl solution | 66.24 μM | Number of G-quadruplexes | 2 |
| G-Score | 18 | Function | Targeted therapy |
| Sequence | CGCAGCAAGGAGATTCGAGGGGGAAGGTTTGTTATAGGGGTTAATGGA | ||
| Applications | Precise diagnosis and target theranostics of multidrug-resistant HCC | ||
| Type | Detail | Type | Detail |
|---|---|---|---|
| ATCC ID | HB-8065 | Cell name | HCC cell (HepG2/MDR) |
| Category | Human cells | Organism | Homo sapiens, human |
| Product type | N/A | Cell type | N/A |
| Morphology | epithelial-like | Tissue | Liver |
| Disease | Carcinoma; Hepatocellular | Product format | Frozen |
| Antigen expression | N/A | Genes expressed | Alpha-fetoprotein (AFP, alpha fetoprotein); albumin; alpha2 macroglobulin (alpha-2-macroglobulin) |
| Cell description | Hep G2 [HEPG2] is a cell line exhibiting epithelial-like morphology that was isolated from a hepatocellular carcinoma of a 15-year-old, White, male youth with liver cancer. The cell line was deposited by the Wistar Institute and is a suitable transfection host. Expression markers include insulin; insulin-like growth factor II (IGF II). |
|
|
| Application(s) | 3D cell culture; Cancer research; High-throughput screening; Toxicology | ||
|
Interaction ID | 879 |
| Target type | Cell | |
| Target unique ID | HB-8065 | |
| Activity | 86.26 nM | |
| Binding Conditions/Buffer | DPBS with glucose (4.5 mg/mL), MgCl2 (5 mM), BSA (1 mg/mL), and yeast tRNA (0.1 mg/mL)) at 37 °C in an orbital shaker for 50 min |
|
| Assay | Quantification analysis of apparent Kd of truncated ZL-7c on target HepG2/MDR cells |
|
| PubMed ID | 34779207 |
| Aptamer ID | Aptamer chemistry | Sequence | Similarity |
|---|---|---|---|
| Apta_794 | DNA | ATCCAGAGTGACGCAGCAAGGAGATTCGAGGGGGAAGGTTTGTTATAGGGGTTAATGGACACGGTGGCTTAGT | |
| Apta_488 | DNA | CGACCAGGGTGGGAGGGGGACGGGCTGGCGGCGCGCGGTAATG | |
| Apta_691 | DNA | CGACGCGCGTTGGTGGTGGATGGTGTGTTACACGTGTTGT | |
| Apta_287 | DNA | CAGCACCGACCTTGTGCTTTGGGAGTGCTGGTCCAAGGGCGTTAATGGACA | |
| Apta_745 | DNA | GGTTGCATGCCGTGGGGAGGGGGGTGGGTTTTATAGCGTACTCAG | |
| Apta_813 | DNA | TAGAGATATGACAGCGGGGAAGGTTAAGAGGCGCTAGGAG | |
| Apta_1255 | DNA | GGCGCATGATCATTCGGTGGGTAAGGTGGTGGTAACGTTG | |
| Apta_988 | DNA | AAGGATGACTGACGACGATGGGAATGGAGAGGAAGGGGATATAGGTATGTTGGATGTAG | |
| Apta_756 | DNA | GGGGGACACGGAGGTGGTGGAAAGGCTAAGATTTGATGATGAGTAGTGTGGT | |
| Apta_150 | DNA | CCGTAGGTTCGGGGCGGAGTGGTCCGGAAGGTGGCGTGG | |
| Apta_341 | DNA | TCGGGGTTTGGGGGTTCGGGGTCGGTTCGGTTTCTTCTAATGGA | |
| Apta_343 | DNA | AACAGAGGGACAAACGGGGGAAGATTTGACGTCGACGAC | |
| Apta_960 | DNA | CCCGAGGCACGAGGGGGAACGTATCGTCATGTGCCGGCCA | |
| Apta_962 | DNA | CCACACCGAGATGTTGTGACGGTTCCGATTGGCAAACTGA | |
| Apta_1091 | DNA | CCATGGTAGGTATTGCTTGGTAGGGATAGTGGGCTTGATG | |
| Apta_1092 | DNA | CCCATGGTAGGTATTGCTTGGTAGGGATAGTGGGCTTGATG | |
| Apta_753 | DNA | GGGCACAGACGGAAGATGAGAATTGTGGGGCTTAGTATAGTGAGGTGCGTGT | |
| Apta_1230 | DNA | GGCGATAGGCAGTGTTGCGGGGTCGGAGAGCGAGGTAATAGCGTGTATGGGTGCTGTGTG | |
| Apta_140 | DNA | GGCAGGAAGACAAACACGATGGGGGGGTATGATTTGATGTGGTTGTTGCATGATCGTGGTCTGTGGTGCTGT | |
| Apta_615 | DNA | ACGAAGAAACAGGGCGCTTCGAACGAACATGGGCAGGGTGGGAAGTTTTAAAGTGGTAC |